Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 602 across all filing types
Latest filing 2024-10-15 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) governing disclosures of share repurchases and treasury share transactions. The content includes detailed tables of share repurchase activity, prices, and confirmations of compliance with exchange rules. There is no indication of this being a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about transactions in the company's own shares. This fits the definition of 'Transaction in Own Shares' (POS) filings, which report share buybacks or sales of treasury shares. The document length (9601 characters) and detailed transactional data support this classification with high confidence.
2024-10-15 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) governing disclosures of share repurchases and treasury share transactions. The content includes detailed tables of share repurchase activity, prices, dates, and confirmations of compliance with exchange rules. There is no indication that this is a full financial report, earnings release, or management discussion. Instead, it is a regulatory disclosure about transactions in the company's own shares. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length and detail confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is POS with high confidence.
2024-10-14 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is a Next Day Disclosure Return filed by Kindstar Globalgene Technology, Inc. It details changes in issued shares and treasury shares, specifically a share repurchase transaction. The document references rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) governing disclosure of share repurchases and changes in issued shares. It includes detailed data on the number of shares repurchased, prices, dates, and confirmations that the repurchases comply with exchange rules. The document is regulatory in nature, reporting share repurchase activity and changes in capital structure, but it is not a full financial report or earnings release. It is not a proxy, AGM material, or management discussion. The content fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or sales of its own shares. The document length and detail support this classification with high confidence.
2024-10-10 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and details changes in issued shares and treasury shares, including share repurchases and treasury share sales. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed transactional data such as number of shares repurchased, prices, and dates. The content is regulatory in nature, focused on disclosure of share capital changes and repurchase activities. It is not a financial report, earnings release, or management discussion, but a regulatory disclosure about share transactions. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length and detail confirm it is the report itself, not just an announcement of a report publication.
2024-10-09 English
UPDATE ON DISCLOSEABLE TRANSACTION - ACQUISITION OF EQUITY INTEREST IN THE TARGET COMPANIES INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE AND THE NEW TARGET CONTRACTUAL ARRANGEMENTS
Capital/Financing Update Classification · 95% confidence The document is an announcement from Kindstar Globalgene Technology, Inc. regarding an update on a discloseable transaction involving acquisition of equity interest and issuance of consideration shares under a general mandate. It discusses conditions precedent, listing rules implications, connected transactions, and waivers related to contractual arrangements. The content is focused on transaction updates and regulatory compliance rather than presenting financial statements or detailed financial performance. The document is about a transaction update and related regulatory disclosures, not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 5170 characters, which is sufficient for a substantive announcement rather than a brief notice or report publication announcement.
2024-10-08 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) governing disclosures of share repurchases and treasury shares. The content includes detailed tables of share repurchase transactions, prices, and confirmations of compliance with exchange rules. This type of document is a regulatory disclosure about share repurchases and treasury share transactions, not a financial report or earnings release. It fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2024-10-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.